Abstract
MR mammography is a highly sensitive (> 98%) and slightly lower specificity (> 80%) method of detecting breast cancer. The sensitivity of MR mammography in detecting low or medium grade DCIS is lower than in detecting invasive carcinomas and high grade DCIS. Achieving the high efficacy of MR mammography is only possible with a very good quality MR examination; this however is not always easy to accomplish. According to EUSOBI 2015 recommendations, the indications for breast MRI are: screening women with a high risk of breast cancer; preoperative staging of newly diagnosed breast cancer; evaluating the response to neoadjuvant chemotherapy; occult primary breast carcinoma (searching for breast cancer in patients with metastases and negative mammography and breast ultrasound); suspected local recurrence whenever needle biopsy proves impossible; assessing breast implants; further characterisation of equivocal lesions found by mammography/breast ultrasound, whenever needle biopsy proves impossible. The introduction of Digital Breast Tomosynthesis (DBT) and contrast-enhanced spectral mammography (CESM) into daily clinical practice in the recent years has created the need to re-analyse the indications for MR mammography and to develop a new breast cancer diagnostic imaging algorithm.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have